These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 24533532

  • 1. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix.
    Yuan G, Wu L, Huang M, Li N, An J.
    Radiat Oncol; 2014 Feb 18; 9():55. PubMed ID: 24533532
    [Abstract] [Full Text] [Related]

  • 2. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ, Liu SP, Wang XE.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):821-7. PubMed ID: 20207507
    [Abstract] [Full Text] [Related]

  • 3. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
    Yokoyama Y, Takano T, Nakahara K, Shoji T, Sato H, Yamada H, Yaegashi N, Okamura K, Kurachi H, Sugiyama T, Tanaka T, Sato A, Tase T, Mizunuma H.
    Oncol Rep; 2008 Jun 01; 19(6):1551-6. PubMed ID: 18497964
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
    Niibe Y, Tsunoda S, Jobo T, Imai M, Matsuo K, Matsunaga K, Unno N, Hayakawa K.
    Eur J Gynaecol Oncol; 2008 Jun 01; 29(3):222-4. PubMed ID: 18592783
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
    Fujiwara M, Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Sumida I, Hayashi K, Kimura T, Ogawa K.
    J Radiat Res; 2015 Mar 01; 56(2):305-14. PubMed ID: 25428244
    [Abstract] [Full Text] [Related]

  • 6. Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.
    Jakubowicz J, Blecharz P, Skotnicki P, Reinfuss M, Walasek T, Luczynska E.
    Eur J Gynaecol Oncol; 2014 Mar 01; 35(4):393-9. PubMed ID: 25118480
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S, Mahantshetty U, Engineer R, Chopra S, Hawaldar R, Hande V, Kerkar RA, Maheshwari A, Shylasree TS, Ghosh J, Bajpai J, Gurram L, Gulia S, Gupta S, Gynecologic Disease Management Group.
    JAMA Oncol; 2018 Apr 01; 4(4):506-513. PubMed ID: 29423520
    [Abstract] [Full Text] [Related]

  • 8. A Phase 1/2 Study of Carbon Ion Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
    Okonogi N, Wakatsuki M, Kato S, Karasawa K, Miyasaka Y, Murata H, Nakano T, Kamada T, Shozu M, Working Group of Gynecological Tumors.
    Int J Radiat Oncol Biol Phys; 2019 Jul 01; 104(3):631-639. PubMed ID: 30825494
    [Abstract] [Full Text] [Related]

  • 9. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T, Makino H, Okubo T, Fujiwara Y, Sawada M, Kuroboshi H, Tsubamoto H, Murakoshi H, Motohashi T, Kitawaki J, Ito K.
    J Obstet Gynaecol Res; 2019 Mar 01; 45(3):671-678. PubMed ID: 30575239
    [Abstract] [Full Text] [Related]

  • 10. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
    Mabuchi S, Ugaki H, Isohashi F, Yoshioka Y, Temma K, Yada-Hashimoto N, Takeda T, Yamamoto T, Yoshino K, Nakajima R, Kuragaki C, Morishige K, Enomoto T, Inoue T, Kimura T.
    Gynecol Obstet Invest; 2010 Mar 01; 69(4):224-232. PubMed ID: 20068328
    [Abstract] [Full Text] [Related]

  • 11. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    Zhang GY, Zhang R, Bai P, Li SM, Zhang YY, Chen YR, Huang MN, Wu LY.
    BMC Cancer; 2022 Dec 20; 22(1):1331. PubMed ID: 36539745
    [Abstract] [Full Text] [Related]

  • 12. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 20; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 13. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S, Kumar L, Pandey RM, Upadhyay A, Roy S, Dadhwal V, Madan R, Chander S.
    Asian Pac J Cancer Prev; 2015 Jan 20; 16(12):5075-9. PubMed ID: 26163644
    [Abstract] [Full Text] [Related]

  • 14. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
    Wang JQ, Wang T, Shi F, Yang YY, Su J, Chai YL, Liu Z.
    Asian Pac J Cancer Prev; 2015 Jan 20; 16(14):5957-61. PubMed ID: 26320479
    [Abstract] [Full Text] [Related]

  • 15. Concurrent Weekly versus Three Weekly Cisplatin with Radiotherapy in Locally Advanced Uterine Cervical Carcinoma.
    Hasan MR, Bari MA, Alam S, Sah GS.
    JNMA J Nepal Med Assoc; 2018 Jan 20; 56(213):842-847. PubMed ID: 31065118
    [Abstract] [Full Text] [Related]

  • 16. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
    Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group.
    Int J Gynecol Cancer; 2012 Oct 20; 22(8):1420-6. PubMed ID: 22932262
    [Abstract] [Full Text] [Related]

  • 17. Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: a phase II study.
    Varghese SS, Ram TS, Pavamani SP, Thomas EM, Jeyaseelan V, Viswanathan PN.
    J Cancer Res Ther; 2014 Oct 20; 10(2):330-6. PubMed ID: 25022387
    [Abstract] [Full Text] [Related]

  • 18. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
    Micheletti E, La Face B, Bianchi E, Cagna E, Apostoli P, Ruggeri G, Verardi R, Sartori E.
    Am J Clin Oncol; 1997 Dec 20; 20(6):613-20. PubMed ID: 9391552
    [Abstract] [Full Text] [Related]

  • 19. Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
    Niibe Y, Onda T, Matsuo K, Inoue Y, Hayakawa K.
    Anticancer Res; 2017 Dec 20; 37(12):6983-6988. PubMed ID: 29187484
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N.
    Gynecol Oncol; 2007 Jan 20; 104(1):36-40. PubMed ID: 16889822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.